Research peptide
Tesamorelin
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) that binds anterior-pituitary GHRH receptors to prompt endogenous GH release. An N-terminal hexenoyl modification extends its half-life and resists enzymatic breakdown, and it is widely used to study pulsatile GH secretion and its metabolic downstream effects. Lyophilised powder, 10mg vial, ≥99% purity by HPLC, Certificate of Analysis on request. UK-based dispatch for preclinical research only. Research applications GHRH receptor binding and pituitary-stimulation studies Pulsatile growth-hormone release pattern research Visceral adipose tissue and lipodystrophy research models IGF-1 axis and downstream metabolic-signalling investigation Body-composition and metabolic-homeostasis studies Specifications Form: Lyophilised powder Purity: ≥99% (HPLC verified) Storage: −20°C, protected from light and moisture Available sizes: 10mg Certificate of Analysis: available on request
Size: 10mg
Multi-buy discount available
- Buy 2Save 5%
- Buy 3Save 10%
- Buy 5Save 15%
- Buy 10Save 20%
- 99%+ purity guaranteed
- COA available
- Same-day dispatch
- Secure checkout
Product details
- Tesamorelin receptor binding and agonism assays in controlled laboratory settings.
- In vitro pathway signalling studies requiring batch-documented research material.
- Analytical method development and HPLC reference characterisation.
- Institutional protocol workstreams that require published Certificates of Analysis.
